People in Oxford who have osteoarthritis of the knee are being invited to take part in a national charity-funded clinical trial to find a more effective treatment.
PhD student Pradeep Kumar Sacitharan, of the Kennedy Institute has won the Medical Sciences Division heat of the Three Minute Thesis (3MT) Competition.
Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.
By changing mouse genes to block a protein associated with obesity, researchers at the Kennedy Institute of Rheumatology, NDORMS have prevented fat from forming around the animals' internal organs, even when the animals eat an unhealthy diet. The study in Nature Medicine found that these genetically engineered mice also retained their sensitivity to insulin (normally blunted by obesity), despite gaining weight.
We are delighted to announce that Pernille S\u00f8gaard and Christine Doherty, both DPhil students at the Kennedy Institute, have been awarded the \u201cPoster Presentation Prize\u201d at the British Society of Matrix Biology (BSMB) Spring Meeting held at St Catherine\u2019s College, Oxford, this March.
We are delighted to announce that Pernille S\u00f8gaard, a 2nd year DPhil student at the Kennedy Institute, NDORMS has received an award for best presentation at the 32nd Winter School on Proteinases and Their Inhibitors held in Tiers an Rosengarten, Italy earlier this month.
New research published today in eLife demonstrates a new function for Wiskott-Aldrich Syndrome (WAS) protein in the activation of T cells, which play a central role in our immune system.
A clinical trial to test a new treatment for Dupuytren\u2019s disease has commenced at the Kennedy Institute and Botnar Research Centre. Affecting 4% of the UK population, this disease causes fingers to curl into the palm and can be extremely disabling.
Dr Thibault Griseri has been awarded a Career Development Fellowship from Arthritis Research UK to explore haematopoietic stem and progenitor cells as novel therapeutic targets in chronic inflammatory arthritis.
The Knee Injury Cohort at the Kennedy (KICK) study has completed a significant milestone this week with the recruitment of all required participants \u2013 150 individuals aged between 18 and 50 with recent knee injuries.
![\"\"](\"https://www.kennedy.ox.ac.uk/news/oxford-osteoarthritis-patients-in-new-clinical-trial/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n